TWST logo

TWSTTwist Bioscience Corp

$67.77
$2.29
(3.27%)
Today
Closed $67.77
$0.67
(0.99%)
After Hours
Updated: 07:40 PM EDT
EarningsAug 3
Mkt Cap$4.36B
Vol1.15M
News
all
press releases
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?
Key PointsDennis Cho sold 14,205 shares on May 29, 2026, for a total transaction value of ~$991,000, at a reported price of $69.75 per share...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Twist Biosciences' (TWST) CEO Sold 16,000 Shares for $1.1 Million
Key Points16,470 common shares were exercised via options and disposed in the open market for a transaction value of ~$1.12 million on May 28, 2026...
Nasdaq News: Markets
News Placeholder
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like PACB, MYGN and TWST.
Zacks
News Placeholder
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist Bioscience will present at the William Blair 46th Annual Growth Stock Conference on Tuesday...
Business Wire
News Placeholder
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results...
Yahoo! Finance: News
News Placeholder
These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results
Twist Bioscience Corp (TWST) reported Q2 loss but exceeded sales guidance. CEO expects profitability and raised FY sales guidance. Analysts raise price targets.read more...
Benzinga
News Placeholder
Company News for May 5, 2026
Companies in The News Are: TSN,TWST,EBAY,GME,XOM
Zacks
News Placeholder
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (Twist or the Company), a mid-cap growth and value biotech company, today announced that a total of...
Business Wire
News Placeholder
AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens
Twist Bioscience posts wider Q2 loss, beats revenue estimates, raises FY26 outlook, and expands gene portfolio.read more...
Benzinga
News Placeholder
Twist Bioscience (NASDAQ:TWST) Stock Price Down 5.3% on Disappointing Earnings
Twist Bioscience (NASDAQ:TWST) Shares Down 5.3% on Disappointing Earnings...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.